Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Cardinal Health ( CAH ) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cardinal Health ( CAH ) Stock Dips While Market Gains: Key Facts
The latest trading day saw Cardinal Health (CAH) settling at $154.46, representing a -2.52% change from its previous close.
Why Cardinal Health ( CAH ) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Medical Stocks Lagging Arcutis Biotherapeutics ( ARQT ) This Year?
Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Cardinal Health (CAH) have performed compared to their sector so far this year.
IDEXX Laboratories Stock Rallies 52.9% YTD: What's Behind the Drive?
IDXX soars 52.9% YTD, fueled by strong CAG Diagnostics growth, global expansion and rising demand for software solutions.
Cardinal ( CAH ) Upgraded to Buy: Here's What You Should Know
Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Why Cardinal Health ( CAH ) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Insulet Stock Surges 37.4% in 12 months: What's Driving the Rally?
PODD stock rallies 37.4% in a year, fueled by Omnipod 5 adoption, global launches and expanding reach in diabetes care.
Cardinal Health ( CAH ) Falls More Steeply Than Broader Market: What Investors Need to Know
In the most recent trading session, Cardinal Health (CAH) closed at $148.96, indicating a -3.64% shift from the previous trading day.
Phibro Animal Health Stock Surges 82.1% YTD: What's Fueling It?
PAHC rallies 82% YTD with booming vaccines, MFAs and global expansion fueling investor confidence.
Should You Hold STERIS Stock in Your Portfolio Right Now?
STE posts solid Healthcare and AST growth with strong liquidity but faces macroeconomic and currency headwinds.
Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now?
DGX posts strong gains from physician and hospital channels while advancing AI-powered solutions.
Should Value Investors Buy Cardinal Health ( CAH ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is it the Right Time to Retain Abbott Stock in Your Portfolio?
ABT's strong Nutrition, Diabetes Care and EPD growth fuel momentum, but macro and currency headwinds challenge its outlook.
Here's Why Cardinal Health ( CAH ) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CAH Strengthens Distribution With New Consumer Health Logistics Hub
Cardinal Health opens a 350,000-square-foot Consumer Health Logistics Center in Ohio, strengthening its pharmaceutical supply chain and advancing its multiyear infrastructure expansion strategy.
Cirtec Medical Welcomes Chris Cleary to its Board of Directors
BROOKLYN PARK, Minn., Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Cirtec Medical is pleased to announce that Chris Cleary has been appointed to its Board of Directors.
The New Olink Target 48 Neurodegeneration Panel May Boost TMO Stock
Thermo Fisher unveils the Olink Target 48 Neurodegeneration panel to accelerate biomarker research in neurodegenerative diseases.
Should You Continue to Hold Integra Stock in Your Portfolio Now?
IART shows strong demand in neurosurgery and Tissue Technologies but faces macro and liquidity challenges.
Cardinal Health ( CAH ) Stock Sinks As Market Gains: Here's Why
Cardinal Health (CAH) reached $150.27 at the closing of the latest trading day, reflecting a -1.29% change compared to its last close.
Should SPDR Russell 1000 Low Volatility Focus ETF ( ONEV ) Be on Your Investing Radar?
Style Box ETF report for ...
Is SPDR Russell 1000 Low Volatility Focus ETF ( ONEV ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Cardinal Health ( CAH ) Stock Outpacing Its Medical Peers This Year?
Here is how Cardinal Health (CAH) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
Cardinal Health Expands At-Home Solutions With New Texas Facility
CAH announces the opening of a new distribution center in Texas, which is likely to support its at-Home Solutions business.
Here's How Much You Would Have Made Owning Cardinal Health Stock In The Last 5 Years - Cardinal Health ( NYSE:CAH )
Cardinal Health CAH has outperformed the market over the past 5 years by 10.67% on an annualized basis producing an average annual return of 24.87%. Currently, Cardinal Health has a market capitalization of $35.64 billion.
Is Cardinal ( CAH ) a Solid Growth Stock? 3 Reasons to Think "Yes"
Cardinal (CAH) could produce exceptional returns because of its solid growth attributes.
Should Value Investors Buy Cardinal Health ( CAH ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What's Driving the Market Sentiment Around Cardinal Health? - Cardinal Health ( NYSE:CAH )
Cardinal Health's CAH short percent of float has risen 38.61% since its last report. The company recently reported that it has 7.62 million shares sold short, which is 4.2% of all regular shares that are available for trading.
Why Cardinal Health ( CAH ) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Add Zimmer Biomet Stock to Your Portfolio Now?
ZBH rides on knee innovation and robotics growth, but debt and macro pressures challenge its upside potential.
Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand
COO's Q3 results may top estimates, powered by strong demand for MyDay lenses, Biofinity gains and surgical product resilience despite fertility softness.
Is Nuveen ESG Mid-Cap Value ETF ( NUMV ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Is Adaptive Biotechnologies ( ADPT ) Outperforming Other Medical Stocks This Year?
Here is how Adaptive Biotechnologies (ADPT) and Cardinal Health (CAH) have performed compared to their sector so far this year.
CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes
CVS Health's Pharmacy & Consumer Wellness unit posts double-digit revenue gains despite ongoing reimbursement headwinds.
BIAF Stock Down Following Q2 Earnings Despite CyPath Lung Growth
bioAffinity shifts its focus on CyPath Lung as the second-quarter 2025 loss widens, with rising adoption and new market expansion underway.
Nuclear Medicine Market is expected to generate a revenue of USD 12.99 Billion by 2032, Globally, at 9.30% CAGR: Verified Market Research®
Lewes, Delaware, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- The Global Nuclear Medicine Market Size is projected to grow at a CAGR of 9.30% from 2026 to 2032, according to a new report published by Verified Market Research®.
5 Dividend Growth Stocks to Boost Your Portfolio
Five dividend growth stocks, AGCO, VRT, TEL, CAH and WWD, stand out for their steady payouts, strong fundamentals and long-term upside potential.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal ( CAH ) is an Incredible Growth Stock: 3 Reasons Why
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
All You Need to Know About Cardinal ( CAH ) Rating Upgrade to Buy
Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should Value Investors Buy Cardinal Health ( CAH ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cardinal Health to Acquire Solaris Health for Urology Expansion
CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
After Plunging 9.1% in 4 Weeks, Here's Why the Trend Might Reverse for Cardinal ( CAH )
The heavy selling pressure might have exhausted for Cardinal (CAH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Brokers Suggest Investing in Cardinal ( CAH ) : Read This Before Placing a Bet
Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Company News for Aug 13, 2025
Companies In The News Are: CAH, SE, CRCL, ONON.
Why Cardinal Health Stock Was Tumbling on Tuesday
The healthcare conglomerate handily beat on the bottom line in its latest reported quarter, but that's not what the market was paying attention to.
Cardinal Health ( CAH ) Tops Q4 Earnings Estimates
Cardinal (CAH) delivered earnings and revenue surprises of +2.46% and -0.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
